2021-09-17

Ivermectin or Bust: FDA Kills the Vaccine Push

ZH: FDA Panel Rejects Broad Pfizer Booster Jabs Scuttling Biden Administration's Plan, Backs Limited Shots

A panel of senior advisors for the FDA voted against approving a third dose of the Pfizer-BioNTech jab for every patient over the age of 16, while leaving a door open to approving booster jabs for a more limited portion of the population including the elderly and the immuno-compromised.

The final vote tally was Yes: 2, No: 16, Abstain: 0.

"There are very clear populations where a booster may be appropriate, such as elderly or immunocompromised," said National Institutes of Health scientist Michael Kurilla. "It’s not clear to me that the data we’re seeing right now is applicable or necessary for the general population."

At one point, panelist Paul Offit questioned the wide framing of the FDA question, and raised concerns about the risk of myocarditis, a kind of heart inflammation, in younger men

My hunch is this may kill the vaccine push. Speaking as one of the unvaccinated, here's my thought process. The vaccine doesn't seem terribly effective, there are side effect risks and, from what I've read, it sounds like hitting the virus with the FLCCC protocol which includes ivermectin-combined with not being high risk-is a better alternative. The FDA is saying the risk from a third shot is not worth the risk, but the efficacy of the vaccines is falling. More people will become infected with SARS2 naturally over time. What's the point in being vaccinated if it fades anyway, and the end result either way is you eventually get infected with SARS2? I'm sure the media, government and vaccine makers will try to spin this back to, "You must take the vaccines now!" If they can't, what's their backup plan? Ivermectin or lockdowns that kill the economy heading into an election year?

1 comment:

  1. I hope you are right but I bet they will phase the boosters in (probably approving the next stage within a couple of months) to make it look better.

    ReplyDelete